Correction: Earl et al. Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival. Cancers 2021, 13, 1612

Cancers (Basel). 2021 Jul 22;13(15):3687. doi: 10.3390/cancers13153687.

Julie Earl^{1

2}, Emma Barreto¹, María E Castillo¹, Raquel Fuentes¹, Mercedes Rodríguez-Garrote¹, Reyes Ferreiro¹, Pablo Reguera¹, Gloria Muñoz³, David Garcia-Seisdedos³, Jorge Villalón López¹, Bruno Sainz Jr^{4

5

6}, Nuria Malats^{2

7}, Alfredo Carrato^{1

2

8}

¹ Molecular Epidemiology and Predictive Tumor Markers Group, Ramón y Cajal Health Research Institute (IRYCIS), Carretera Colmenar Km 9100, 28034 Madrid, Spain.
² Biomedical Research Network in Cancer (CIBERONC), C/Monforte de Lemos 3-5. Pabellón 11, 28029 Madrid, Spain.
³ Translational Genomics Core Facility, Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid, Spain.
⁴ Department of Biochemistry, Universidad Autónoma de Madrid (UAM), Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid, Spain.
⁵ Instituto de Investigaciones Biomédicas "Alberto Sols" (IIBM), CSIC-UAM, C/Arzobispo Morcillo, 4, 28029 Madrid, Spain.
⁶ Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3-IRYCIS, 28029 Madrid, Spain.
⁷ Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
⁸ Department of Medicine and Medical Specialties, Medicine Faculty, Alcala University, Plaza de San Diego, s/n, 28801 Alcalá de Henares, Spain.

Abstract

The authors wish to make the following corrections to this paper [...].